NDC product
Astepro Allergy
NDC 0280-0065 · Bayer HealthCare LLC.
Key facts
| Product NDC | 0280-0065 |
|---|---|
| Proprietary name | Astepro Allergy |
| Nonproprietary name | Azelastine HCl |
| Substances | AZELASTINE HYDROCHLORIDE |
| Dosage form | SPRAY, METERED |
| Route | NASAL |
| Labeler | Bayer HealthCare LLC. |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA |
| Application number | NDA213872 |
| Pharmacologic classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| Marketing start | Jun 27, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: